Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.055 USD | -0.16% | -9.55% | -9.96% |
05-14 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
05-14 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.82% | 297M | |
+11.06% | 115B | |
+12.79% | 106B | |
-4.52% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.29% | 17.56B | |
-39.36% | 17.32B | |
+7.51% | 14.03B | |
+32.89% | 12.13B |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Poseida Therapeutics President Mark Gergen Named CEO, Wll Succeed Eric Ostertag in February